FDA Regulation Catches Up To Next-Gen Gene Sequencing
On Sept. 9, the U.S. Food and Drug Administration announced plans to host two public workshops on "next-generation sequencing" (NGS) that may provide greater clarity regarding the regulatory framework for personalized...To view the full article, register now.
Already a subscriber? Click here to view full article